Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiopharmaceuticals for diagnosis and treatment: Progress report for the period November 1, 1968 through July 1, 1987

Technical Report ·
OSTI ID:6155423
This project has been directed to the evolution of labeled chemicals useful for nuclear medical imaging to trace adrenal functions and localizing tumors in the neuroendocrine system. A major success was the introduction of T I-metaiodobenzylguanidine (MIBG). The uptake of radiolabeled precursors of epinephrine was explored. The uptake and excretion of five C-14 labeled precursors of epinephrine was studied in dogs. The adrenal medulla uptake of C-14 dopamine exceeded that of all other precursors. During the initial attempts to synthesize a successful adrenal medulla imaging agent, the concentration of C-14 dopamine in the human neuroblastoma was found to be considerably greater than in the normal human adrenal medulla. Radioiodinated bretylium analog was prepared that images the dog adrenal medulla. This effort was rapidly followed by the synthesis of original compounds with structural similarities to both norepinephrine and the adrenergic neuronal blocking agent, guanethidine; these latter agents demonstrating greater adrenal medulla specificity than the bretylium analogs. One of these guanidine derivatives, T I-metaiodobenzylguanidine (MIBG) has permitted the first successful diagnostic imaging of human adrenal medullary hyperplasia and of pheochromocytomas (including metastasized carcinoma) which could not be localized by any existing methodologies.
Research Organization:
Michigan Univ., Ann Arbor (USA). Div. of Nuclear Medicine
DOE Contract Number:
AC02-76EV02031
OSTI ID:
6155423
Report Number(s):
DOE/EV/02031-17; ON: DE87013088
Country of Publication:
United States
Language:
English

Similar Records

Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines
Journal Article · Tue Jan 31 23:00:00 EST 1984 · J. Med. Chem.; (United States) · OSTI ID:6746983

Radiopharmaceuticals for diagnosis and treatment. A.E.C. competing renewal, 1974
Technical Report · Mon Dec 31 23:00:00 EST 1973 · OSTI ID:4310349

Update on basic research and clinical experience with metaiodobenzylguanidine
Journal Article · Wed Dec 31 23:00:00 EST 1986 · Med. Pediatr. Oncol.; (United States) · OSTI ID:5850794